Benchling Stock

Cloud-Based Research Platform

Sign up today and learn more about Benchling Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2012

Notable Investors

Andreessen Horowitz

Headquarters

San Francisco CA, US

Total Funding

$425M

About Benchling Stock

Benchling is a modern software platform purpose-built for life science R&D. Benchling claims its platform can help manage techniques like CRISPR, CAR-T immunotherapy, and genetic engineering with a suite of cloud applications to design DNA and collaborate on experiments, manage research workflows, and make critical R&D decisions. Benchling is used for research on biotherapeutics, biofuels, and biomaterials at life science companies and academic labs. 

Benchling was founded in 2012 and is headquartered in San Francisco, California, United States. Notable investors include Thrive Capital, Y Combinator, and SV Angel.

Investors

Funding History

January 2015$6.1M
April 2016$7.0M
March 2018$18.2M
April 2019$37.0M
March 2020$50.5M
March 2021$200M
October 2021$95.0M
October 2021$11.0M

Management

Chief Executive Officer

Sajith Wickramasekara

Chief Financial Officer

Richard Wong

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo